Aligos Therapeutics, Inc. (ALGS) Insider Ownership

Historic Insider Ownership Trends

Through the 90-day period concluding February 19, 2026, Aligos Therapeutics's top three insider stakeholders include Director Carole Nuechterlein (441.04K shares), Chief Executive Officer Lawrence Blatt (73.90K shares), Director James Paul Scopa (7.32K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Carole Nuechterlein 441,038 27 Oct, 2023
Lawrence Blatt Chief Executive Officer 73,903 27 Oct, 2023
James Paul Scopa 7,323 27 Oct, 2023
Thomas Woiwode 178 15 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
25 Oct, 2023 Lawrence Blatt Common Stock A 610,277 $0.76 73,903 D A
25 Oct, 2023 James Paul Scopa Common Stock A 183,083 $0.76 7,323 D A
25 Oct, 2023 Carole Nuechterlein Common Stock A 7,933,601 $0.76 441,038 I P
11 Jun, 2021 Thomas Woiwode - - 0 I
11 Jun, 2021 Thomas Woiwode Common Stock D 9,719 $0.00 0 I J
11 Jun, 2021 Thomas Woiwode Common Stock A 2,226 $0.00 178 D J
11 Jun, 2021 Thomas Woiwode Common Stock A 9,719 $0.00 389 I J
11 Jun, 2021 Thomas Woiwode - - 0 I
11 Jun, 2021 Thomas Woiwode - - 389 I
11 Jun, 2021 Thomas Woiwode Common Stock A 8,383 $0.00 335 I J
11 Jun, 2021 Thomas Woiwode - - 335 I
11 Jun, 2021 Thomas Woiwode Common Stock D 485,979 $0.00 58,317 I J
11 Jun, 2021 Thomas Woiwode - - 58,317 I
11 Jun, 2021 Thomas Woiwode Common Stock D 8,383 $0.00 0 I J
26 Apr, 2021 Thomas Woiwode Common Stock D 8,385 $0.00 0 I J
26 Apr, 2021 Thomas Woiwode Common Stock D 9,720 $0.00 0 I J
26 Apr, 2021 Thomas Woiwode Common Stock A 2,226 $0.00 89 D J
26 Apr, 2021 Thomas Woiwode Common Stock A 9,720 $0.00 389 I J
26 Apr, 2021 Thomas Woiwode - - 89 D
26 Apr, 2021 Thomas Woiwode Common Stock A 8,385 $0.00 335 I J